Publication | Open Access

Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69 + lymphocytes correlate with effects of Theratope® sialyl-Tn-KLH cancer vaccine in active specific immunotherapy

Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityTherapeutic VaccineImmunotherapeuticsActive Specific ImmunotherapyImmunotherapyOncologyRadiation OncologyCancer ResearchPre-immunotherapy Serum Ca27.29